title: Hyperreactivity of platelets to serotonin (5-hydroxytryptamine) in patients with cardiovascular diseases. Influence of ketanserin, a serotonin S2-receptor antagonist.
authors.affiliation: Clinical Research Unit St Bartholomeus, Jan Palfijn Hospital, Merksem, Belgium.
authors.forename: J
authors.initials: J
authors.lastname: De Crée
authors.forename: V
authors.initials: V
authors.lastname: Roels
authors.forename: H
authors.initials: H
authors.lastname: Verhaegen
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002318:Cardiovascular Diseases / Q000097:blood*; D006801:Humans; D007650:Ketanserin / Q000494:pharmacology*; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*; D011446:Prospective Studies; D012701:Serotonin / Q000494:pharmacology*
chemical_list: D012701:Serotonin; D007650:Ketanserin